← All trials
NCT05756504
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 22, 2023
- Primary completion
- Jan 20, 2024
- Completion date
- Feb 20, 2024
- First posted
- Mar 6, 2023
- Last posted
- Apr 6, 2023
- Enrollment
- 130
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hayatabad Medical ComplexLead sponsor
- Hayatabad Medical ComplexReponsible party - principal investigator
- Hayatabad Medical ComplexStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.